Showing 8571-8580 of 8876 results for "".
- Scioderm Initiates Phase IIB Study of SD-101 to Treat Epidermolysis Bullosahttps://practicaldermatology.com/news/20140107-scioderm_initiates_phase_iib_study_of_sd-101_to_treat_epidermolysis_bullosa/2459377/
- Suneva Medical Announces 12-Month Safety Results From Artefill® Acne Scar Studyhttps://practicaldermatology.com/news/20140107-suneva_medical_announces_12-month_safety_results_from_artefill_acne_scar_study/2459379/Suneva Medical Inc. announced the 12-month follow-up data from its randomized, double-blinded, multi-center, Pivotal acne scar investigational study evaluating the safety and efficacy of ArteFillâ, a dermal filler, to treat acne scars.
- Promius Pharma®, LLC Introduces Isotretinoin Indigent Patient Assistance Programhttps://practicaldermatology.com/news/20140106-promius_pharma_llc_introduces_isotretinoin_indigent_patient_assistance_program/2459381/Promius Pharma is introducing a Promius Promise Patient Assistance Program for eligible patients who are uninsured, or whose insurance company does not provide coverage of isotretinoin and who otherwise meet program eligibility requirements. This program, which is integrated into the Promius Promise
- Mela Sciences Announces Realignment of Boardhttps://practicaldermatology.com/news/20140103-mela_sciences_announces_realignment_of_board/2459382/
- Cutera Appoints Scott Ashworth as Executive Vice President of Global Saleshttps://practicaldermatology.com/news/20131230-cutera_appoints_scott_ashworth_as_executive_vice_president_of_global_sales/2459385/Scott Ashworth recently joined Cutera as Executive Vice President of Global Sales. He brings twenty-five years of experience in building and leading global sales and marketing teams focused on commercialization of products, establishing distributio
- Almirall S.A. to Aquire Aqua Pharmaceuticalshttps://practicaldermatology.com/news/20131217-almirall_sa_to_aquire_aqua_pharmaceuticals/2459392/
- Cynosure Announces Successful Settlement of Patent Infringement Lawsuitshttps://practicaldermatology.com/news/20131217-cynosure_announces_successful_settlement_of_patent_infringement_lawsuits/2459393/Cynosure, Inc. will receive $10 million plus future royalty payments under a comprehensive settlement agreement with Tria Beauty, Inc. that ends the patent infringement litigation between Tria and Palomar Medical Technologies, which
- Valeant Pharmaceuticals to Acquire Solta Medicalhttps://practicaldermatology.com/news/20131216-valeant_pharmaceuticals_to_acquire_solta_medical/2459394/Valeant Pharmaceuticals International, Inc. announced that it has entered into a definitive agreement to acquire all of the outstanding common stock
- Mela Sciences Reports Positive Feedback on MelaFind during Clinical Advisory Meetinghttps://practicaldermatology.com/news/20131210-mela_sciences_reports_positive_feedback_on_melafind_during_clinical_advisory_meeting/2459396/
- Cutera Announces Enhancements to its Sales and Marketing Organizationhttps://practicaldermatology.com/news/20131127-cutera_announces_enhancements_to_its_sales_and_marketing_organization/2459400/Cutera, Inc. recently announced enhancements to its sales and marketing organization. Kevin Connors, President and CEO of Cutera, stated, "We are pleased with our portfolio of product offerings and ex